Yves Bousquet

Discovery of BI 224436, a Noncatalytic Site Integrase Inhibitor (NCINI) of HIV-1

Lee D. Fader, Éric Malenfant, Mathieu Parisien et al. · ACS Medicinal Chemistry Letters · 2014 · 180 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Discovery of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of inhibitors of HIV-1 capsid assembly

Lee D. Fader, Richard C. Bethell, Pierre Bonneau et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 104 citations

Pharmacy, Chemistry, Medicinal Chemistry +12

Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery and preliminary SAR of benzimidazole derivatives

Pierre L. Beaulieu, Michael Bös, Yves Bousquet et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 103 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency

Pierre L. Beaulieu, Michael Bös, Yves Bousquet et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 90 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Discovery of a Potent and Selective Noncovalent Linear Inhibitor of the Hepatitis C Virus NS3 Protease (BI 201335)

Montse Llinàs‐Brunet, Murray D. Bailey, Nathalie Goudreau et al. · Journal of Medicinal Chemistry · 2010 · 89 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16